PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Tóm tắt
Both the programmed death (PD) 1–PD-ligand (PD-L) pathway and regulatory T (T reg) cells are instrumental to the maintenance of peripheral tolerance. We demonstrate that PD-L1 has a pivotal role in regulating induced T reg (iT reg) cell development and sustaining iT reg cell function. PD-L1−/− antigen-presenting cells minimally convert naive CD4 T cells to iT reg cells, showing the essential role of PD-L1 for iT reg cell induction. PD-L1–coated beads induce iT reg cells in vitro, indicating that PD-L1 itself regulates iT reg cell development. Furthermore, PD-L1 enhances and sustains Foxp3 expression and the suppressive function of iT reg cells. The obligatory role for PD-L1 in controlling iT reg cell development and function in vivo is illustrated by a marked reduction in iT reg cell conversion and rapid onset of a fatal inflammatory phenotype in PD-L1−/−PD-L2−/− Rag−/− recipients of naive CD4 T cells. PD-L1 iT reg cell development is mediated through the down-regulation of phospho-Akt, mTOR, S6, and ERK2 and concomitant with the up-regulation of PTEN, all key signaling molecules which are critical for iT reg cell development. Thus, PD-L1 can inhibit T cell responses by promoting both the induction and maintenance of iT reg cells. These studies define a novel mechanism for iT reg cell development and function, as well as a new strategy for controlling T reg cell plasticity.
Từ khóa
Tài liệu tham khảo
Adler, 2007, Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells, Blood., 109, 4351, 10.1182/blood-2006-09-047563
Baecher-Allan, 2003, CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo, Novartis Found. Symp., 252, 67, 10.1002/0470871628.ch6
Barber, 2006, Restoring function in exhausted CD8 T cells during chronic viral infection, Nature., 439, 682, 10.1038/nature04444
Battaglia, 2006, Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients, J. Immunol., 177, 8338, 10.4049/jimmunol.177.12.8338
Belkaid, 2008, Role of Foxp3-positive regulatory T cells during infection, Eur. J. Immunol., 38, 918, 10.1002/eji.200738120
Beswick, 2007, Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells, Infect. Immun., 75, 4334, 10.1128/IAI.00553-07
Bettelli, 2003, Myelin oligodendrocyte glycoprotein–specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis, J. Exp. Med., 197, 1073, 10.1084/jem.20021603
Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature., 441, 235, 10.1038/nature04753
Blank, 2005, Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy, Cancer Immunol. Immunother., 54, 307, 10.1007/s00262-004-0593-x
Bloom, 2008, CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H, Am. J. Transplant., 8, 793, 10.1111/j.1600-6143.2007.02134.x
Broeren, 2000, Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile, J. Immunol., 165, 6908, 10.4049/jimmunol.165.12.6908
Brown, 2003, Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production, J. Immunol., 170, 1257, 10.4049/jimmunol.170.3.1257
Brunkow, 2001, Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse, Nat. Genet., 27, 68, 10.1038/83784
Calzascia, 2008, CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity, Proc. Natl. Acad. Sci. USA., 105, 2999, 10.1073/pnas.0712135105
Chen, 2003, Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3, J. Exp. Med., 198, 1875, 10.1084/jem.20030152
Clark, 1999, Cellular and molecular characterization of the scurfy mouse mutant, J. Immunol., 162, 2546, 10.4049/jimmunol.162.5.2546
Coenen, 2007, Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells, Bone Marrow Transplant., 39, 537, 10.1038/sj.bmt.1705628
Collison, 2007, The inhibitory cytokine IL-35 contributes to regulatory T-cell function, Nature., 450, 566, 10.1038/nature06306
Coombes, 2007, A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism, J. Exp. Med., 204, 1757, 10.1084/jem.20070590
Das, 2006, Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection, J. Immunol., 176, 3000, 10.4049/jimmunol.176.5.3000
Dong, 2002, Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion, Nat. Med., 8, 793, 10.1038/nm730
Dorfman, 2006, Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma, Am. J. Surg. Pathol., 30, 802, 10.1097/01.pas.0000209855.28282.ce
Fantini, 2004, Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7, J. Immunol., 172, 5149, 10.4049/jimmunol.172.9.5149
Fontenot, 2003, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nat. Immunol., 4, 330, 10.1038/ni904
Fontenot, 2005, Regulatory T cell lineage specification by the forkhead transcription factor foxp3, Immunity., 22, 329, 10.1016/j.immuni.2005.01.016
Gao, 2007, Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells, Am. J. Transplant., 7, 1722, 10.1111/j.1600-6143.2007.01842.x
Gavin, 2007, Foxp3-dependent programme of regulatory T-cell differentiation, Nature., 445, 771, 10.1038/nature05543
Haxhinasto, 2008, The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells, J. Exp. Med., 205, 565, 10.1084/jem.20071477
Hill, 2007, Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature, Immunity., 27, 786, 10.1016/j.immuni.2007.09.010
Hirano, 2005, Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity, Cancer Res., 65, 1089, 10.1158/0008-5472.1089.65.3
Hori, 2003, Control of regulatory T cell development by the transcription factor Foxp3, Science., 299, 1057, 10.1126/science.1079490
Huber, 2008, P38 MAP kinase signaling is required for the conversion of CD4+CD25- T cells into iTreg, PLoS One., 3, e3302, 10.1371/journal.pone.0003302
Inman, 2007, PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression, Cancer., 109, 1499, 10.1002/cncr.22588
Iwai, 2002, Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade, Proc. Natl. Acad. Sci. USA., 99, 12293, 10.1073/pnas.192461099
Joetham, 2008, Plasticity of regulatory T cells: subversion of suppressive function and conversion to enhancement of lung allergic responses, J. Immunol., 180, 7117, 10.4049/jimmunol.180.11.7117
Keir, 2006, Tissue expression of PD-L1 mediates peripheral T cell tolerance, J. Exp. Med., 203, 883, 10.1084/jem.20051776
Keir, 2007, PD-1 and its ligands in T-cell immunity, Curr. Opin. Immunol., 19, 309, 10.1016/j.coi.2007.04.012
Keir, 2007, PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues, J. Immunol., 179, 5064, 10.4049/jimmunol.179.8.5064
Keir, 2008, PD-1 and its ligands in tolerance and immunity, Annu. Rev. Immunol., 26, 677, 10.1146/annurev.immunol.26.021607.090331
Kim, 2007, Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice, Nat. Immunol., 8, 191, 10.1038/ni1428
Konishi, 2004, B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression, Clin. Cancer Res., 10, 5094, 10.1158/1078-0432.CCR-04-0428
Kronenberg, 2005, Regulation of immunity by self-reactive T cells, Nature., 435, 598, 10.1038/nature03725
Krupnick, 2005, Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells, J. Immunol., 175, 6265, 10.4049/jimmunol.175.10.6265
Latchman, 2004, PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells, Proc. Natl. Acad. Sci. USA., 101, 10691, 10.1073/pnas.0307252101
Liang, 2005, Conversion of CD4+ CD25− cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus, J. Exp. Med., 201, 127, 10.1084/jem.20041201
Lin, 2007, Regulatory T cell development in the absence of functional Foxp3, Nat. Immunol., 8, 359, 10.1038/ni1445
Lohr, 2006, Regulatory T cells in the periphery, Immunol. Rev., 212, 149, 10.1111/j.0105-2896.2006.00414.x
Long, 2008, Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells, J. Autoimmun., 30, 293, 10.1016/j.jaut.2007.12.012
Luo, 2008, Cutting edge: TGF-beta-induced expression of Foxp3 in T cells is mediated through inactivation of ERK, J. Immunol., 180, 2757, 10.4049/jimmunol.180.5.2757
Marie, 2005, TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells, J. Exp. Med., 201, 1061, 10.1084/jem.20042276
Nakanishi, 2007, Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers, Cancer Immunol. Immunother., 56, 1173, 10.1007/s00262-006-0266-z
Nomi, 2007, Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer, Clin. Cancer Res., 13, 2151, 10.1158/1078-0432.CCR-06-2746
Ohigashi, 2005, Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer, Clin. Cancer Res., 11, 2947, 10.1158/1078-0432.CCR-04-1469
Probst, 2005, Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4, Nat. Immunol., 6, 280, 10.1038/ni1165
Pyzik, 2007, TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets, J. Leukoc. Biol., 82, 335, 10.1189/jlb.1006644
Qu, 2007, The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice, Transpl. Immunol., 17, 153, 10.1016/j.trim.2007.01.002
Ramsdell, 2003, Foxp3 and natural regulatory T cells: key to a cell lineage?, Immunity., 19, 165, 10.1016/S1074-7613(03)00207-3
Riley, 2002, Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors, Proc. Natl. Acad. Sci. USA., 99, 11790, 10.1073/pnas.162359999
Roncarolo, 2007, Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans, Nat. Rev. Immunol., 7, 585, 10.1038/nri2138
Rubtsov, 2007, TGFbeta signalling in control of T-cell-mediated self-reactivity, Nat. Rev. Immunol., 7, 443, 10.1038/nri2095
Sakaguchi, 2008, Regulatory T cells and immune tolerance, Cell., 133, 775, 10.1016/j.cell.2008.05.009
Sauer, 2008, T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR, Proc. Natl. Acad. Sci. USA., 105, 7797, 10.1073/pnas.0800928105
Schubert, 2001, Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation, J. Biol. Chem., 276, 37672, 10.1074/jbc.M104521200
Setoguchi, 2005, Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization, J. Exp. Med., 201, 723, 10.1084/jem.20041982
Sharpe, 2007, The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection, Nat. Immunol., 8, 239, 10.1038/ni1443
Strauss, 2007, Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin, J. Immunol., 178, 320, 10.4049/jimmunol.178.1.320
Strome, 2003, B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma, Cancer Res., 63, 6501
Tang, 2008, The Foxp3+ regulatory T cell: a jack of all trades, master of regulation, Nat. Immunol., 9, 239, 10.1038/ni1572
Tang, 2003, Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells, J. Immunol., 171, 3348, 10.4049/jimmunol.171.7.3348
Thompson, 2004, Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target, Proc. Natl. Acad. Sci. USA., 101, 17174, 10.1073/pnas.0406351101
Williams, 2007, Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3, Nat. Immunol., 8, 277, 10.1038/ni1437
Winstead, 2008, Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells, J. Immunol., 180, 7305, 10.4049/jimmunol.180.11.7305
Wu, 2006, Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance, Acta Histochem., 108, 19, 10.1016/j.acthis.2006.01.003
Yang, 2008, Molecular antagonism and plasticity of regulatory and inflammatory T cell programs, Immunity., 29, 44, 10.1016/j.immuni.2008.05.007